BACKGROUND: Patients with serious mental illness (SMI) have high rates of cardiovascular disease (CVD). In contrast to widespread perception, their access to effective chronic disease management is as high as for the general population. However, previous studies have not included analysis by ethnicity. AIM: To identify differences in CVD and diabetes management, by ethnicity, among people with SMI. DESIGN AND SETTING: Three inner east London primary care trusts with an ethnically diverse and socially deprived population. Data were obtained from 147 of 151 general practices. METHOD: Coded demographic and clinical data were obtained from GP electronic health records using EMIS Web. The sample used was the GP registered population on diabetes or CVD registers (52,620); of these, 1223 also had SMI. RESULTS: The population prevalence of CVD and diabetes is 7.2%; this rises to 18% among those with SMI. People with SMI and CVD or diabetes were found to be as likely to achieve clinical targets as those without SMI. Blood pressure control was significantly better in people with SMI; however, they were more likely to smoke and have a body mass index above 30 kg/m(2). Ethnic differences in care were identified, with south Asian individuals achieving better cholesterol control and black African or Caribbean groups achieving poorer blood pressure control. CONCLUSION: Risk factor management for those with SMI shows better control of blood pressure and glycosylated haemoglobin than the general population. However, smoking and obesity rates remain high and should be the target of public health programmes. Ethnic differences in management mirror those in the general population. Ethnic monitoring for vulnerable groups provides evidence to support schemes to reduce health inequalities.
BACKGROUND:Patients with serious mental illness (SMI) have high rates of cardiovascular disease (CVD). In contrast to widespread perception, their access to effective chronic disease management is as high as for the general population. However, previous studies have not included analysis by ethnicity. AIM: To identify differences in CVD and diabetes management, by ethnicity, among people with SMI. DESIGN AND SETTING: Three inner east London primary care trusts with an ethnically diverse and socially deprived population. Data were obtained from 147 of 151 general practices. METHOD: Coded demographic and clinical data were obtained from GP electronic health records using EMIS Web. The sample used was the GP registered population on diabetes or CVD registers (52,620); of these, 1223 also had SMI. RESULTS: The population prevalence of CVD and diabetes is 7.2%; this rises to 18% among those with SMI. People with SMI and CVD or diabetes were found to be as likely to achieve clinical targets as those without SMI. Blood pressure control was significantly better in people with SMI; however, they were more likely to smoke and have a body mass index above 30 kg/m(2). Ethnic differences in care were identified, with south Asian individuals achieving better cholesterol control and black African or Caribbean groups achieving poorer blood pressure control. CONCLUSION: Risk factor management for those with SMI shows better control of blood pressure and glycosylated haemoglobin than the general population. However, smoking and obesity rates remain high and should be the target of public health programmes. Ethnic differences in management mirror those in the general population. Ethnic monitoring for vulnerable groups provides evidence to support schemes to reduce health inequalities.
Authors: Laurel A Copeland; John E Zeber; Chen-Pin Wang; Michael L Parchman; Valerie A Lawrence; Marcia Valenstein; Alexander L Miller Journal: BMC Health Serv Res Date: 2009-07-26 Impact factor: 2.655
Authors: Paul Fearon; James B Kirkbride; Craig Morgan; Paola Dazzan; Kevin Morgan; Tuhina Lloyd; Gerard Hutchinson; Jane Tarrant; Wai Lun Alan Fung; John Holloway; Rosemarie Mallett; Glynn Harrison; Julian Leff; Peter B Jones; Robin M Murray Journal: Psychol Med Date: 2006-08-29 Impact factor: 7.723
Authors: Hayley McBain; Kathleen Mulligan; Frederique Lamontagne-Godwin; Julia Jones; Mark Haddad; Chris Flood; David Thomas; Alan Simpson Journal: BMC Psychiatry Date: 2016-07-08 Impact factor: 3.630
Authors: Kathleen Mulligan; Hayley McBain; Frederique Lamontagne-Godwin; Jacqui Chapman; Mark Haddad; Julia Jones; Chris Flood; David Thomas; Alan Simpson Journal: Health Expect Date: 2017-03-17 Impact factor: 3.377
Authors: Hayley McBain; Frederique Lamontagne-Godwin; Mark Haddad; Alan Simpson; Jacqui Chapman; Julia Jones; Chris Flood; Kathleen Mulligan Journal: BMJ Open Date: 2018-02-15 Impact factor: 2.692
Authors: Jayati Das-Munshi; Peter Schofield; Mark Ashworth; Fiona Gaughran; Sally Hull; Khalida Ismail; John Robson; Robert Stewart; Rohini Mathur Journal: BMJ Open Diabetes Res Care Date: 2021-09
Authors: Chandra Sarkar; Hiten Dodhia; James Crompton; Peter Schofield; Patrick White; Christopher Millett; Mark Ashworth Journal: BMC Fam Pract Date: 2015-08-07 Impact factor: 2.497
Authors: J Das-Munshi; M Ashworth; F Gaughran; S Hull; C Morgan; J Nazroo; A Roberts; D Rose; P Schofield; R Stewart; G Thornicroft; M J Prince Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2016-02-04 Impact factor: 4.328